Showing results (361-370 of 515) with videos related to

Sort By:
Pageof 52
Crohn'S & Colitis 360|May 25, 2026
Gestational weight gain and birth outcomes in a large Canadian cohort of pregnant persons with inflammatory bowel diseaseDerek M Nguyen, Parul Tandon, Vivek Govardhanam, et al.
Crohn'S & Colitis 360|June 1, 2026
A real-world observational study of second-line anti-TNFα treatment in patients with ulcerative colitis who received vedolizumab as a first-line biologicChiahung Chou, Marie Sanchirico, Precious A Anyanwu, et al.
Crohn'S & Colitis 360|February 17, 2023
Use of Exclusive Enteral Formula Diet as Adjunctive Therapy for Treatment of a Crohn's Disease FlareLevi M Teigen, Abigail J Johnson, Eugenia Shmidt, et al.
Crohn'S & Colitis 360|September 11, 2023
IBD Camp Oasis: A look at Participants' Social-Emotional Well-Being and Protective Factors During Camp and BeyondNamita Singh, Steven J Steiner, Rebecca Fauth, et al.
Crohn'S & Colitis 360|July 9, 2026
Paradigm shift in inflammatory bowel disease management-advanced therapy utilization, persistence, and outcomes in a United Arab Emirates cohort during 2015-2025Hosameldin Abdelrahman Ahmed, Mohamed Nasir Alzaabi, Thaer Khaleel Swaid, et al.
Crohn'S & Colitis 360|July 11, 2026
Mirikizumab is equally effective in ustekinumab-exposed and ustekinumab-naïve patients with UC: a multicenter real-world cohortMohmmed Tauseef Sharip, Dharmaraj Durai, Eva Vayreda, et al.
Crohn'S & Colitis 360|August 1, 2026
Induction-phase infliximab monitoring accelerates time to remission in pediatric IBD: a retrospective cohort studyNicholas Iovino, Samantha R Paglinco, Mahmoud Abdel-Rasoul, et al.
Crohn'S & Colitis 360|August 2, 2026
Bowel urgency in ulcerative colitis is associated with clinical endpoints, health-related quality of life, and biomarkers: data from the etrasimod ELEVATE UC 52 trialMarla C Dubinsky, Erica R Cohen, Peter M Irving, et al.
Crohn'S & Colitis 360|August 1, 2026
Nutrition management and self-perceived relapse triggers in patients with inflammatory bowel disease: results from the 3R web-based surveyMotohiro Esaki, Takayuki Matsumoto, Fumihito Hirai, et al.
Crohn'S & Colitis 360|July 16, 2026
Partial enteral nutrition combined with an exclusion diet promotes a healthy gut microbiome in patients with mild to moderately active ulcerative colitis: a quasi-experimental studySudheer K Vuyyuru, Divya Madan, Sourav Goswami, et al.
Pageof 52